Sell4

Chime Financial, Inc.

CHYM

Total Value

$14.7M

Net $14.7M sold

Filing Date

Sep 16, 2026

7 transactions

Sales

$14.7M

7 transactions

Trade Summary

On Sep 14, 2026 through Sep 16, 2026, Feuille James, Insider, sold $14.7M of Chime Financial, Inc. (CHYM) across 7 transactions. The filing covers Class A Common Stock and reflects net selling of $14.7M. Reported prices ranged from $31.46 to $34.41. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.

Price at the Time of the Trade

CHYM daily price with the insider's sale marked at $32.89.

Sold near the 6-month high · the stock trades 2% higher today.

Price data is delayed and provided for context only — not investment advice.

Insider Information

Name: Feuille James
Role: Insider
Location: SAN FRANCISCO, CA

Filing Details

Filing Date: Sep 16, 2026
Transaction Date: Sep 14, 2026
Accession Number: 0001318214-26-000009
Form Type: 4
Net Trading Amount: -$14.7M

Non-Derivative Transactions

Date	Security	Shares	Price	Type	Value
Sep 14, 2026	Class A Common Stock	93,428	$34.08	Sale	$3.2M
Sep 14, 2026	Class A Common Stock	1,972	$34.41	Sale	$67.9K
Sep 15, 2026	Class A Common Stock	94,446	$33.20	Sale	$3.1M
Sep 15, 2026	Class A Common Stock	954	$33.95	Sale	$32.4K
Sep 16, 2026	Class A Common Stock	62,218	$31.46	Sale	$2.0M
Sep 16, 2026	Class A Common Stock	33,182	$32.19	Sale	$1.1M
Sep 16, 2026	Class A Common Stock	161,437	$32.70	Sale	$5.3M

Want live alerts when Feuille James trades again?

Download Insider Trades to track CHYM, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.

iOS App Android App

Footnotes

(F1)The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $33.36 to $34.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
(F2)Shares are directly held by Crosslink Crossover Fund VI, L.P. ("CO VI"). Crossover Fund VI Management, L.L.C. ("CF VI Mgr") is the general partner of CO VI and the Reporting Person is a managing member of CF VI Mgr. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
(F3)The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $34.40 to $34.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
(F4)The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $32.90 to $33.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
(F5)The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $30.87 to $31.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
(F6)The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $31.87 to $32.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
(F7)The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $32.38 to $33.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
(F8)The shares held by Crosslink Ventures VII Holdings, LLC ("CV VII Hldgs") as reported herein reflect the receipt of shares pursuant to pro rata distributions in kind, effected by CB VII and CB VII-B, for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
(F9)The shares held by CV VII Hldgs as reported herein reflect pro rata distributions in kind, effected by CV VII Hldgs to its members for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
(F10)Shares are directly held by CV VII Hldgs. The Reporting Person is a managing member of CV VII Hldgs and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
(F11)The shares held by Crosslink Ventures VII, L.P. ("CV VII") as reported herein reflect pro rata distributions in kind, effected by CV VII to its general partner and limited partners for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
(F12)Shares are directly held by CV VII. Crosslink Ventures VII Holdings, LLC ("CV VII Hldgs") is the general partner of CV VII and the Reporting Person is a managing member of CV VII Hldgs. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
(F13)The shares held by Crosslink Ventures VII-B, L.P. ("CV VII-B") as reported herein reflect pro rata distributions in kind, effected by CV VII-B to its general partner and limited partners for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
(F14)Shares are directly held by CV VII-B. CV VII Hldgs is the general partner of CV VII-B and the Reporting Person is a managing member of CV VII Hldgs. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
(F15)The shares held by Crosslink Bayview VII, LLC ("CB VII") as reported herein reflect pro rata distributions in kind, effected by CB VII to its members for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
(F16)Shares are directly held by CB VII. CV VII Hldgs is the manager of CB VII and the Reporting Person is a managing member of CV VII Hldgs. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
(F17)The shares reported herein reflect the receipt of shares pursuant to a pro rata distribution in kind, effected by CB VII, for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
(F18)The shares are held by an irrevocable trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his proportionate pecuniary interest therein.
(F19)The shares are held by a revocable trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his proportionate pecuniary interest therein.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Feuille James

(Last)

(First)

(Middle)

C/O CHIME FINANCIAL, INC.

101 CALIFORNIA STREET, SUITE 500

(Street)

SAN FRANCISCO

94111

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Chime Financial, Inc. [ CHYM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/14/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	09/14/2026		S		93,428	D	$34.08⁽¹⁾	6,753,479	I	By Crosslink Crossover Fund VI, L.P.⁽²⁾
Class A Common Stock	09/14/2026		S		1,972	D	$34.41⁽³⁾	6,751,507	I	By Crosslink Crossover Fund VI, L.P.⁽²⁾
Class A Common Stock	09/15/2026		S		94,446	D	$33.2⁽⁴⁾	6,657,061	I	By Crosslink Crossover Fund VI, L.P.⁽²⁾
Class A Common Stock	09/15/2026		S		954	D	$33.95	6,656,107	I	By Crosslink Crossover Fund VI, L.P.⁽²⁾
Class A Common Stock	09/16/2026		S		62,218	D	$31.46⁽⁵⁾	6,593,889	I	By Crosslink Crossover Fund VI, L.P.⁽²⁾
Class A Common Stock	09/16/2026		S		33,182	D	$32.19⁽⁶⁾	6,560,707	I	By Crosslink Crossover Fund VI, L.P.⁽²⁾
Class A Common Stock	09/16/2026		S		161,437	D	$32.7⁽⁷⁾	0⁽⁸⁾⁽⁹⁾	I	By Crosslink Ventures VII Holdings, LLC⁽¹⁰⁾
Class A Common Stock								8,275,067⁽¹¹⁾	I	By Crosslink Ventures VII, L.P.⁽¹²⁾
Class A Common Stock								3,545,896⁽¹³⁾	I	Crosslink Ventures VII-B, L.P.⁽¹⁴⁾
Class A Common Stock								876,661⁽¹⁵⁾	I	By Crosslink Bayview VII, LLC⁽¹⁶⁾
Class A Common Stock								148,746⁽¹⁷⁾	I	By Trust⁽¹⁸⁾
Class A Common Stock								45,246	I	By Trust⁽¹⁹⁾
Class A Common Stock								23,315	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $33.36 to $34.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

2. Shares are directly held by Crosslink Crossover Fund VI, L.P. ("CO VI"). Crossover Fund VI Management, L.L.C. ("CF VI Mgr") is the general partner of CO VI and the Reporting Person is a managing member of CF VI Mgr. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

3. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $34.40 to $34.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

4. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $32.90 to $33.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

5. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $30.87 to $31.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

6. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $31.87 to $32.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

7. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $32.38 to $33.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

8. The shares held by Crosslink Ventures VII Holdings, LLC ("CV VII Hldgs") as reported herein reflect the receipt of shares pursuant to pro rata distributions in kind, effected by CB VII and CB VII-B, for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.

9. The shares held by CV VII Hldgs as reported herein reflect pro rata distributions in kind, effected by CV VII Hldgs to its members for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.

10. Shares are directly held by CV VII Hldgs. The Reporting Person is a managing member of CV VII Hldgs and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

11. The shares held by Crosslink Ventures VII, L.P. ("CV VII") as reported herein reflect pro rata distributions in kind, effected by CV VII to its general partner and limited partners for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.

12. Shares are directly held by CV VII. Crosslink Ventures VII Holdings, LLC ("CV VII Hldgs") is the general partner of CV VII and the Reporting Person is a managing member of CV VII Hldgs. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

13. The shares held by Crosslink Ventures VII-B, L.P. ("CV VII-B") as reported herein reflect pro rata distributions in kind, effected by CV VII-B to its general partner and limited partners for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.

14. Shares are directly held by CV VII-B. CV VII Hldgs is the general partner of CV VII-B and the Reporting Person is a managing member of CV VII Hldgs. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

15. The shares held by Crosslink Bayview VII, LLC ("CB VII") as reported herein reflect pro rata distributions in kind, effected by CB VII to its members for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.

16. Shares are directly held by CB VII. CV VII Hldgs is the manager of CB VII and the Reporting Person is a managing member of CV VII Hldgs. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

17. The shares reported herein reflect the receipt of shares pursuant to a pro rata distribution in kind, effected by CB VII, for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.

18. The shares are held by an irrevocable trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his proportionate pecuniary interest therein.

19. The shares are held by a revocable trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his proportionate pecuniary interest therein.

	/s/ James Feuille	09/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Form 4 as rendered by the SEC from accession 0001318214-26-000009.

Chime Financial, Inc.

Trade Summary

Price at the Time of the Trade

Company Information

Insider Information

Filing Details

Non-Derivative Transactions

Want live alerts when Feuille James trades again?

Footnotes

SEC Form 4

SEC Filing

SEC Form 4

Price at the Time of the Trade